|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Vacuolar-sorting protein SNF8 (aa 1-258) |
| EAP30 Swiss Prot# | | Q96H20 |
| EAP30 Protein names | | Vacuolar-sorting protein SNF8 (ESCRT-II complex subunit VPS22) (hVps22) (ELL-associated protein of 30 kDa) |
| EAP30 Gene names | | SNF8 EAP30 |
| Organism | | Human |
| EAP30 Entry name | | SNF8_HUMAN |
| EAP30 Codon optimized cDNA(gene) Clone |
| EAP30 Cat # | | RPS0794 |
| Tag | | EAP30 contains A 6x histidine tag |
| EAP30 Formulation | | Liquid |
| EAP30 Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| EAP30 Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant EAP30 Protein |
| EAP30 Cat # | | PS0794 |
| EAP30 Source | | recombinant |
| EAP30 Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| EAP30 Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| EAP30 Activity | | N/A |
| Tag | | EAP30 Contains A 6x histidine tag |
| EAP30 Formulation | | Liquid |
| EAP30 Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant EAP30 Products | | For pricing and availability Click Here >>> |
| EAP30 family | | SNF8 family |
| EAP30 Subcellular locations | | Cytoplasm. Endosome membrane. Nucleus. Late endosome membrane. |
| EAP30 FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: Component of the endosomal sorting complex required for transport II (ESCRT-II), which is required for multivesicular body (MVB) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-II complex is probably involved in the recruitment of the ESCRT-III complex. The ESCRT-II complex may also play a role in transcription regulation by participating in derepression of transcription by RNA polymerase II, possibly via its interaction with ELL. Required for degradation of both endocytosed EGF and EGFR, but not for the EGFR ligand-mediated internalization. It is also required for the degradation of CXCR4. |
| EAP30 Sequence | | DDBJ | EMBL | GenBank |
| EAP30 3D structure | | ModBase |
| EAP30 interaction | | STRING |
| EAP30 Proteomic | | PRIDE |
| EAP30 Genome annotation | | Ensembl | GeneID | KEGG | UCSC |
| EAP30 Organism specific | | CTD | MGI |
| EAP30 Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| EAP30 Gene expression | | Bgee | ArrayExpress | Genevestigator |
| EAP30 Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |